Pharma AI Tracker

A Lilly speaker at AWS re:Invent 2025 described a multi-agent system that lets non-technical staff query healthcare datasets in plain language, shortening data evaluation from months to weeks.

Partners: AWS

A custom LLM application that drafts informed consent forms from a trial protocol and template, with human review. Vertex data scientists report it has supported more than ten trials.

Microsoft reports that Pfizer has built and deployed more than 300 Copilot Studio agents across the company.

Partners: Microsoft

Vendor case study: Weights & Biases says GSK and Microsoft collaborated on AIGA, an internal framework for generative AI and agentic solutions.

Partners: Microsoft, Weights & Biases

Vendor case study: Weights & Biases says GSK built manufacturing digital twins at three levels of sophistication, with real-time sensors feeding ML workflows that predict batch trajectories, and that GSK has optimized 13 key products this way.

Partners: Weights & Biases

Weights & Biases says GSK now uses agents that detect anomalies, present root-cause hypotheses to the brand manager and simulate downstream scenarios, in an agentic supply-chain setup built with Microsoft.

Partners: Microsoft, Weights & Biases

Weights & Biases says GSK replaced a two-person check of environmental petri dishes with a one-person-plus-AI deep-learning system, operating across nine manufacturing sites and about 3 million images a year.

Partners: Weights & Biases

MSD and AWS explored a retrieval-augmented generative AI approach to help investigators handle manufacturing deviations, keeping generation to lower-risk steps with human oversight.

Partners: AWS

Teva unveiled Teva Rise, an open innovation platform that connects startups with Teva around technologies including AI, industry 4.0 smart manufacturing, digital health and biotech. The first cohort is a set of challenges for partners, not a statement that those AI systems are already running.

A multi-agent assistant built with Azure Logic Apps Agent Loop that pulls knowledge from many internal systems and helps employees find information faster.

Partners: Microsoft

Vertex's CEO said AI is helping streamline work such as preparing regulatory filings, which usually take six to nine months. Reported secondhand from a public event.

Microsoft says UCB created SKAI, a generative-AI platform, and that SKAI powers a family of AI assistants from medical writing to clinical statistics. On the same page a UCB speaker anticipates Microsoft 365 Copilot active use moving from 50% of employees to 80%.

Partners: Microsoft

At its Breda plant Amgen uses cameras, analytics, chatbots over maintenance reports and ML disruption prediction to run operations more efficiently.

Takeda is the founding partner in TetraScience's program to re-platform scientific data for AI use in R&D and CMC.

Partners: TetraScience

An AI assistant trained on Takeda's internal investigation standard that helps staff write more consistent deviation investigation reports.

AbbVie uses AI- and ML-powered analytics on decades of historical data to predict which clinical trial sites will activate quickly.

AstraZeneca runs a company-wide AI upskilling programme, and employees who reach a set accreditation level get early access to an internal AI agent builder, which produced over 1,500 agents in two months.

An in-house generative AI documentation platform built on Claude via Amazon Bedrock with MongoDB Atlas for drafting regulatory documents such as clinical study reports. Anthropic reports large time savings.

Partners: Anthropic, AWS, MongoDB

A field platform that gives sales reps AI-generated views of each doctor's patient population, prescribing patterns and access barriers. It was an award finalist write-up, not a Takeda release.

On its risk-management page, Shionogi lists business-model and operations reform through practicing AI drug discovery among the responses to its digital-transformation risk.

The same risk-management list includes market inventory prediction using AI as part of Shionogi's business-model and operations reform.

Merck KGaA's Life Science business signed an MoU with Siemens; joint projects include developing AI-driven tools and digital interfaces that simplify complex scientific processes.

Partners: Siemens

GSK announced a new $1.2 billion US investment in advanced manufacturing facilities and AI and advanced digital technologies, including new AI and digital capabilities across its five existing US manufacturing sites.

Lilly launched TuneLab, giving biotech companies access to its drug discovery AI models through a third-party hosted, federated-learning setup that protects each party's data.

Gilead broke ground on a biologics Technical Development Center it says will feature digitally enabled systems, autonomous robotics and real-time monitoring. The company describes the site as one of the biopharma industry's most AI-enabled centers.